Clients

Arch Therapeutics, Inc.

Company Snapshot: Arch Therapeutics, Inc.

ARTH
Last Change Volume High Low

Company Overview

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Featured Documents

Client News

  1. Dec 20 2018 Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
  2. Dec 17 2018 Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
  3. Dec 6 2018 Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
  4. Dec 4 2018 Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court